Chiltern

Year Founded

1982

Ownership

Private

Employees

~10001

Stage

Commercial

Modalities

Small moleculeLarge moleculeProtein therapeutics

Chiltern General Information

Global CRO providing clinical development services, acquired by LabCorp/Covance in 2017 for $1.2B

Contact Information

Website

Primary Industry

[ "CRO" ]

Corporate Office

London,
United Kingdom

Drug Pipeline

No pipeline data available

For full access to Chiltern's pipeline data

Key Partnerships

Medidata Solutions

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Chiltern Funding

Deal Type	Date	Amount	Status	Stage
Later Stage VC	Apr 21, 2015	$1.3M	Completed	Commercial

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

To view Chiltern's complete valuation and funding history, request access »